Lovelace Biomedical is excited to be presenting data on the non-clinical and clinical development work for HFA-152a at the upcoming RDD meeting:
Scientists Philip Kuehl and Jacob McDonald will both be in attendance. If you have any interest in meeting with them reach out and make time to set up a meeting.